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Abstract
The airway epithelium forms a barrier against infection but also produces antimicrobial peptides (AMPs) and other
inflammatory mediators to activate the immune system. It has been shown that in allergic disorders, Th2 cytokines
may hamper the antimicrobial activity of the epithelium. However, the presence of Th2 cytokines also affects the
composition of the epithelial layer which may alter its function. Therefore, we investigated whether exposure of
human primary bronchial epithelial cells (PBEC) to Th2 cytokines during mucociliary differentiation affects
expression of the human cathelicidin antimicrobial protein (hCAP18)/LL-37 and human beta defensins (hBD), and
antimicrobial activity.
PBEC were cultured at an air-liquid interface (ALI) for two weeks in the presence of various concentrations of IL-4
or IL-13. Changes in differentiation and in expression of various AMPs and the antimicrobial proteinase inhibitors
secretory leukocyte protease inhibitor (SLPI) and elafin were investigated as well as antimicrobial activity.
IL-4 and IL-13 increased mRNA expression of hCAP18/LL-37 and hBD-2. Dot blot analysis also showed an increase
in hCAP18/LL-37 protein in apical washes of IL-4-treated ALI cultures, whereas Western Blot analysis showed
expression of a protein of approximately 4.5 kDa in basal medium of IL-4-treated cultures. Using sandwich ELISA
we found that also hBD-2 in apical washes was increased by both IL-4 and IL-13. SLPI and elafin levels were not
affected by IL-4 or IL-13 at the mRNA or protein level. Apical wash obtained from IL-4- and IL-13-treated cultures
displayed increased antimicrobial activity against Pseudomonas aeruginosa compared to medium-treated cultures.
In addition, differentiation in the presence of Th2 cytokines resulted in increased MUC5AC production as has been
shown previously.
These data suggest that prolonged exposure to Th2 cytokines during mucociliary differentiation contributes to
antimicrobial defence by increasing the expression and release of selected antimicrobial peptides and mucus.
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Background
The airway epithelium is a pseudostratified columnar
epithelium containing basal, secretory and ciliated cells.
This layer constantly regenerates through migration,
proliferation and differentiation of epithelial cells to
form a barrier to protect against inhaled pathogens. In
addition to its barrier function, the epithelium provides
mucociliary clearance and releases a variety of mediators
such as antimicrobial peptides (AMPs; e.g. the human
cathelicidin LL-37 and human beta-defensins [hBD])
and cytokines like the chemokine CXCL8 (interleukin
[IL]-8). These mediators initiate and regulate the inflam-
matory response by inducing recruitment of phagocytes
such as neutrophils and monocytes. Due to the influx of
these cells and their released compounds local tissue
injury occurs. To counteract this injury, the airway
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secretory leukocyte proteinase inhibitor (SLPI) and elafin
[1,2], which also display antimicrobial activity in vitro
against bacteria, fungi and certain viruses (e.g. HIV) [3-6].
Th2 cytokines are expressed in the airways of asth-
matics [7,8]. Various studies including our own [9] have
indicated that Th2 cytokines are able to influence the
phenotype of the airway epithelium. Animal models
have shown that Th2 cytokines such as IL-13 induce
goblet cell hyperplasia [10] and in vitro studies of
epithelial cell cultures have shown that the presence of
IL-13 during mucociliary differentiation increases goblet
cell hyperplasia [11], increases mRNA expression of
mucins, decreases mRNA expression of ciliated cell
markers FOXJ1, tektin and the novel marker ciliated
bronchial epithelial-1 (CBE-1) [12], and increases
MUC5AC protein expression [13]. Likewise, it was
shown that also IL-4 can drive differentiation of cul-
tured human airway epithelial cells towards a mucus
hypersecretory phenotype [13].
We have previously shown that differentiation of air-
way epithelium markedly affects its function as squa-
mous differentiation of PBEC results in release of more
eotaxin-2/CCL24, whereas mucociliary differentiated
PBEC (due to the presence of high concentrations of
retinoic acid) release more eotaxin-3/CCL26 [9]. In that
study [9], we have also shown that presence of IL-4 (or
IL-13 to a lesser extent) during the differentiation phase
resulted in increased expression of these eotaxins, as
well as in an altered epithelial layer.
Antimicrobial defence is thought to be reduced in Th2
driven diseases such as asthma and atopic dermatitis
(AD). Studies in atopic dermatitis (AD) patients have
shown that the expression of antimicrobial peptides
(LL-37, hBD-2 and -3) and proteinase inhibitors (SLPI
and elafin) in skin is reduc e dc o m p a r e dt op s o r i a t i c
skin. This could explain the increased susceptibility of
AD patients to skin infection [14,15]. Since AD is a Th2
driven disease, these data suggest that the Th2 cytokine
milieu may be detrimental for the antimicrobial defence
provided by epithelial cells. Indeed, in cultured keratino-
cytes, IL-4 and IL-13 reduce the TNF-a/IFN-g-induced
hBD-2 and hBD-3 expression [16]. In addition, IL-13
was shown to reduce LL-37 expression in keratinocytes
[17]. Not only in skin, but also in the airways Th2 cyto-
kines may affect antimicrobial defence both in vitro and
in vivo [18]. First, in cell culture experiments Th2 cyto-
kines reduced the ability of differentiated human bron-
chial epithelial cells to clear Pseudomonas aeruginosa
and the associated increase in hBD-2 mRNA expression.
Second, inducing allergic airways inflammation in mice
resulted in decreased pulmonary clearance of P. aerugi-
nosa and a decrease in CRAMP, the murine homologue
of hCAP18/LL-37, in lung lavage fluid [18].
In asthma the constantly regenerating epithelium is
exposed to Th2 cytokines during differentiation rather
than after differentiation, which leads to goblet cell
hyperplasia and increased mucus production, but may
also affect other functions of the epithelial layer such as
antimicrobial defence. Therefore, in the present study
we investigated the effect of presence of Th2 cytokines
during mucociliary differentiation on host defence, in
particular expression of the antimicrobial peptides LL-
3 7 ,h B D - 2 ,a n d- 3 ,a n dt h ea n t i m i c r o b i a lp r o t e i n a s e
inhibitors SLPI and elafin. In addition, we investigated
effects of Th2 cytokine-induced differentiation on mor-
phology and antimicrobial activity of our cultures.
Materials and methods
Culture of human airway epithelial cells
Primary bronchial epithelial cells (PBEC) were obtained
from anonymized tumour-freel u n gt i s s u eo b t a i n e da t
lung resection surgery for lung cancer by enzymatic
digestion as described previously [19]. Cells from pas-
sage 2 were cultured at an air- liquid interface as
described previously [9]. In short, cultures were grown
submerged for 4-7 days until they reached confluence,
after which they were cultured at an air-liquid interface
(ALI) for another 2 weeks in medium containing a high
concentration of retinoic acid (15 ng/ml; Lonza, Breda,
The Netherlands) to induce mucociliary differentiation.
IL-4 or IL-13 (Peprotech, Rocky Hill, NJ) was added
during these two weeks of culture at the ALI (see Figure 1).
Mucociliary differentiation was usually observed between
day 7 and 10 after exposure to air-liquid interface. ALI
cultures were maintained for 14 days at 37°C in a humi-
dified atmosphere of 5% CO2. The apical side of the
epithelial layers was washed with warm PBS three times a
week; medium and stimuli were refreshed at the same
time. At the end of the 14-day ALI culture period
(48 hours after the last addition of stimulus), basal med-
ium (BM) was harvested and frozen until further use.
The apical side of the epithelial cultures was incubated
with 100 μl of PBS containing 1% N-Acetyl-L-cysteine
(Sigma-Aldrich) for 15 minutes at room temperature to
dissolve mucus threads; this apical wash (AW) was frozen
until further use.
RNA isolation, reverse transcription and polymerase chain
reaction
RNA was isolated at the end of the 14-day ALI culture
using the Qiagen RNeasy Minikit (Qiagen, Valencia, CA)
in combination with the Qiagen RNase-Free DNase Set
(Qiagen, Valencia, CA); an additional DNAseI treatment
was performed to remove residual chromosomal DNA.
Subsequently, RNA was cleaned using a tenth volume
3 M Sodium Acetate (pH 5.2), 2 volumes ice cold ethanol
absolute and precipitation overnight at -20°C. The RNA
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optical density measurements using the NanoDrop
ND-1000 UV-Vis Spectrophotometer (Nanodrop Tech-
nologies, Wilmington, DE). Reverse transcription of
500 ng of total RNA was performed using 200 U of
M o l o n e ym u r i n el e u k e m i av i r u sr e v e r s et r a n s c r i p t a s e
(Invitrogen); 0.5 mM of dATP, dCTP, dGTP, dTTP (Invi-
trogen); 0.5 μg of oligo(dT)15 primer (Promega, Madison,
WI); RNasin RNase inhibitor 40 U (Promega); 10 mM
dithiothreitol (Invitrogen); 50 mM Tris-HCl (pH 8.3);
75 mM KCl; and 3.0 mM MgCl2 in a total volume of 20 μl.
PCR was performed at 95°C for 4 minutes followed by
25 or 35 cycles 15 seconds denaturing, 15 seconds
annealing and 30 seconds amplification using 0.5 pmol
gene specific primers (table 1); nucleotide mix (Invitro-
gen, Breda, The Netherlands) in a final concentration of
0.08 mM each; 1 U of GoTaq Flexi DNA polymerase
(Promega, Madison, WI); 5 μlo f5 ×G r e e nG o T a qF l e x i
reaction buffer (Promega) and different concentrations
of MgCl2 in a final volume of 25 μl. b-actin was used as
a reference gene. Products were visualised using a 1.5%
agarose gel containing ethidium bromide.
Quantitative real time Polymerase Chain Reaction
Quantitative real time PCR was performed on a MyiQ
Single-Color Real-Time PCR detection system with IQ5
software (Bio-Rad Laboratories, Veenendaal, The Neth-
erlands) using IQ SYBR Green supermix containing
3m MM g C l 2 (Bio-Rad) and gene specific primers
(table 2). Samples were analysed in triplicate and each
PCR included a no-template control and a standard
curve in duplicate, made from a sample containing the
appropriate cDNA. PCR was performed at 95°C for 4
minutes followed by 40 cycles of 15 seconds denaturing,
15 seconds annealing and 30 seconds amplification;
fluorescence was measured after each amplification step.
A melt curve analysis was performed to determine the
primer specificity and the absence of primer dimers.
Bio-Rad IQ5 software was used to calculate relative
mRNA quantity using the relative standard curve
method and to normalize the expression of the genes of
interest to both reference genes (GAPDH and b-actin).
MUC5AC and hCAP18/LL-37 dot blot
To determine whether MUC5AC protein and hCAP18/
LL-37 protein were released by ALI cultures, apical washes
of the cultures were diluted and spotted on a methanol-
preincubated polyvinylidene-difluoride (PVDF)-membrane
using a Bio-Dot Microfiltration apparatus (Bio-Rad). For
MUC5AC, non-specific binding sites were blocked with
PBS/5% w/v skim milk (Fluka, Buchs, Switzerland) over-
night at 4°C, and subsequently the membrane was incu-
bated with 2 μg/ml of mouse-anti-MUC5AC (clone 45M1;
Labvision Neomarkers, Fremont, CA) in PBS/5% (w/v)
skim milk for 1 h at room temperature. For hCAP18/
LL-37, a similar protocol was used. After spotting the
seeding
4-7 days
submerged
culture 
ALI
14 days of differentiation
Analyze:
Expression of antimicrobial peptide and SLPI/elafin
Antimicrobial activity
or
Morphology and markers of ciliated and goblet cells
refresh medium -/+ IL-4 or IL-13
3 times a week
Harvest  apical wash, basal medium and RNA 
or
fix cells
Figure 1 Schematic representation of the air-liquid interface (ALI) culture model. Primary bronchial epithelial cells were seeded onto
transwell filters and allowed to grow to confluence for 4-7 days. Cells were exposed to air at the apical side (air-liquid interface; ALI) and
stimulated for 14 days at the basal side with medium (containing high concentrations of retinoic acid to induce mucociliary differentiation). To
investigate effects of IL-4 or IL-13 on differentiating cells, IL-4 or IL-13 was added to the basal medium when cells were first exposed to air;
medium with or without IL-4 or IL-13 was refreshed three times a week.
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PBS/5% (v/v) heat-inactivated newborn calf serum (NBCS;
Gibco, Grand Island, NY)/5% (v/v) skim milk (Fluka,
Buchs, Switzerland) for 2 h at room temperature. Subse-
quently, the membrane was incubated overnight at 4°C
with monoclonal anti-LL-37 antibody 1.1C12 (2 μg/ml) in
PBS/5% (v/v) heat-inactivated NBCS/5% (w/v) skim milk.
A HRP-conjugated goat-anti-mouse IgG (subclasses 1+2a
+2b+3antibody) (Jackson ImmunoResearch Laboratory,
Bar Harbor, ME) was used as a secondary antibody for
MUC5AC and a HRP-conjugated goat-anti-mouse Ig anti-
body (Dako) for the LL-37 dot blot and detected using
ECL Western Blotting substrate (Pierce, Rockford, IL).
Densitometry was performed using Totallab image analysis
software (Nonlinear Dynamics, Newcastle upon Tyne, UK).
hCAP18/LL-37 Western Blot
Basal media, apical washes and cell lysates were har-
vested after 14 days of culture. Four ml of BM and 200
μl of AW were pooled per stimulus, concentrated using
Oasis HLB 1cc extraction cartridges (Waters Chromoto-
graphy, Etten-Leur, The Netherlands), and subjected to
SDS-PAGE on a 16.5% Tris-Tricine gel as described ear-
lier [20]. After protein separation, proteins were blotted
onto PVDF for 1.5 h and subsequently blocked with
PBS/5% (v/v) heat-inactivated NBCS/5% (w/v) skim
milk. The monoclonal mouse anti-hCAP18/LL-37 clone
1.1.C12 (diluted 1:1000) in combination with goat-anti-
mouse-HRP (Dako; diluted 1:1000) or a polyclonal rab-
bit-anti-hCAP18/LL-37 (Innovagen; diluted 1:200)
together with swine-anti-rabbit-HRP (Dako: diluted
1:1000) in combination with ECL were used to detect
hCAP18/LL-37. Synthetic LL-37 (0.5 ng) and a nasal
secretion sample were used as positive controls for LL-
37 and hCAP18 respectively. Kaleidoscope polypeptide
standard (Bio-Rad) was used as a molecular weight
marker.
Measurement of protein levels of antimicrobial peptides
hCAP18/LL-37, hBD-2, hBD-3 and the antimicrobial
protease inhibitors SLPI and elafin
All proteins were measured using well-established sand-
wich ELISAs. hCAP18/LL-37 and elafin/SKALP levels
were measured using commercially available kits (Hycult
Table 1 Primers used for RT-PCR
Name Primer sequence Melting temperature (°C) MgCl2 (mM) Product size (base pairs)
b-actin F:GGAAGGCTGGAAGAGTGC
R:CTACAATGAGCTGCGTGTGG
56 2 528
hCAP18/LL-37 F:GGCTCCTTTGACATCAGTT
R:CTGTCCTGGGTACAAGATTCC
55 2.5 150
hBD-2 F:ATCAGCCATGAGGGTCTTG
R:GCAGCATTTTGTTCCAGG
62 2 190
hBD-3 F:AGCCTAGCAGCTATGAGGATC
R:CTTCGGCAGCATTTTGCGCCA
62 2 206
MUC5AC F:ATTTTTTCCCCACTCCTGATG
R:AAGACAACCCACTCCCAACC
58 2 146
MUC2 F:GACGCACTGTATCATCAAACG
R:AGGATGGTCGTGTTGATGCG
58 2 409
CBE-1 F:GGTCAGAGCTTGAGGTAGCATGTG
R:GAGTTGTAACAGCACACTGCATTC
60 3 395
Tektin F:AGCTGGCTGATCATCTGGCCAAG
R:GGATTTCCTCATCTGCATACACAG
60 2 358
Table 2 Primers used for quantitative real time PCR
Name Primer Sequence Melting Temperature (°C) Product size (base pairs)
b-actin F: TGCGTGACATTAAGGAGAAG
R: TGAAGGTAGTTTCGTGGATG
63 213
GAPDH F: TTCCAGGAGCGAGATCCCT
R: CACCCATGACGAACATGGG
62 259
hCAP18/LL-37 F: TCATTG CCCAGGTCCTCAG
R: TCCCCATACACCGCTTCAC
64.3 249
MUC5AC F: CCTTCGACGGACAGAGCTAC
R: TCTCGGTGACAACACGAAAG
63.5 111
SLPI F: CCAGGGAAGAAGAGATGTTG
R: CCTCCATATGGCAGGAATC
61 226
Elafin F: CCGCTGCTTGAAAGATACTG
R: GAATGGGAGGAAGAATGGAC
59.2 177
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were measured using the human beta-defensin-3 ELISA
kit (Phoenix Pharmaceuticals, Karlsruhe, Germany).
SLPI release was measured using a sandwich ELISA as
described earlier [21], and hBD-2 levels were measured
as previously described [22].
Antimicrobial assay
The antimicrobial assay was adapted from Diamond et
al. [23]. ALI cultures of PBEC were established. Two
days prior to harvesting, medium was replaced by anti-
biotics-free growth medium and the last stimulation
with IL-4 and IL-13 was performed. Apical wash was
harvested using 70 μl of 10 mM sodium phosphate buf-
fer pH 7.4 and stored at -20°C. 250 colony forming
units (CFU) of mid-log phase Pseudomonas aeruginosa
strain PAO1 (BAA-47, American Type Culture Collec-
tion, Rockville, MD, USA) were inoculated into AW
(42.5 μl bacteria added to 7.5 μl of AW) and left shaking
for 3 hours at 37°C. The number of CFU/ml was deter-
mined by plating serial dilutions on LB agar plates; colo-
nies were counted after overnight incubation at 37°C.
Morphology of air-liquid interface cultures
The morphology of the cultures was assessed using light
microscopy and transmission electron microscopy
(TEM). At the end of the cultures, cells were fixed using
a solution of 1% paraformaldehyde (Merck)/1.5% glutar-
aldehyde (BDH Laboratory Supplies, Poole, UK)/0.1 M
sodium cacodylate buffer (pH 7.4, Merck) for 20 min-
utes at room temperature, washed in cacodylate buffer,
post-fixed using 1% osmium tetraoxide (BDH) in 0.1 M
sodium cacodylate buffer for 10 minutes, rinsed in dis-
tilled H2O and dehydrated in ethanol. Subsequently the
filters were embedded in 1:1 epon (PolyBed, Poly-
sciences, Germany)/ethanol absolute for at least one
hour, followed by a 2:1 epon/ethanol absolute for
another hour. Filters were then embedded in pure epon
in a mould and the epon was allowed to polymerize at
60°C for at least 24 hours. One micron sections were
stained using 1% Toluidin Blue and viewed with a Leica
DM/RB microscope and sequential ultra-thin sections
were examined in a JEOL JEM-1011 electron micro-
scope with digital photography using a MegaView III
camera.
Immunofluorescence staining of MUC5AC in air-liquid
interface cultures
ALI cultures were fixed in 1% w/v paraformaldehyde
(Merck) in PBS. Subsequently, the filters were blocked
with PBS/1% w/v BSA/0.05% v/v Tween-20 for 30 min-
utes at 4°C, washed with PBS and incubated with
methanol for 20 minutes at 4°C. After washing with
PBS, primary antibodies were incubated overnight at 4°
C (mouse-anti-MUC5AC clone 45M1 at 0.2 μg/ml); fol-
lowed by washing with PBS and incubation with Alexa
Fluor-labeled secondary antibodies (goat-anti-mouse IgG
(H+L)-Alexa Fluor 488 for 2 h at 4°C. After washing
with PBS, filters were mounted on glass slides, covered
with Vectashield (Vector Laboratories, Burlingame, CA)
and a coverglass. Pictures were taken using a confocal
Laser Scanning Microscope (Zeiss LSM510; Zeiss, Jena,
Germany).
Statistics
Results are expressed as mean ± SEM. Data were ana-
lyzed using the non-parametric Wilcoxon signed ranks
test. Differences at p values smaller than 0.05 were con-
sidered statistically significant.
Results
Two-week exposure of differentiating bronchial epithelial
cells to IL-4 or IL-13 enhances hCAP18/LL-37 and hBD-2
mRNA expression as well as hCAP18/LL-37 protein release
To study how exposure to IL-4 or IL-13 during differen-
tiation of bronchial epithelial cells affects expression of
antimicrobial peptides, we exposed PBEC that were cul-
tured at the ALI to various concentrations of these cyto-
kines for 14 days to induce differentiation (see Figure 1).
Both IL-4 and IL-13 enhanced mRNA expression of
hCAP18/LL-37 and hBD-2 in ALI cultures using cells
from five different donors (Figure 2A). hBD-3 mRNA
expression was very low in the ALI cultures (data not
shown). IL-4 and IL-13 increased hCAP18/LL-37 pro-
tein release as assessed by dot blot analysis of apical
washes obtained from two ALI cultures using cells from
t h es a m et w od o n o r s( F i g u r e2 B ) .U s i n gas a n d w i c h
ELISA for hCAP18/LL-37 with a lower detection limit
of 100 pg/ml, we were not able to detect the protein in
apical wash or basal medium. However, using SDS-
PAGE and Western Blot analysis, we show that concen-
trated basal medium of ALI cultures treated with IL-4
contain a protein of approximately 4.5 kDa (Figure 2C),
suggesting that hCAP18 is cleaved into a smaller frag-
ment which could either be LL-37 or other peptides
known to be cleaved from hCAP18 [24]. hBD-2 protein
level in apical washes was increased by both IL-4 and
IL-13 (Figure 2D), whereas in basal medium it was not.
hBD-3 protein release into apical washes as measured
by ELISA was variable: it was undetectable in cultures
from two out of six donors; IL-4 induced hBD-3 protein
release in cultures of two donors, whereas it decreased
hBD-3 protein release in cultures of two other donors
(data not shown). We did not assess effects of IL-13 on
hBD-3 expression.
These data show that exposure to Th2 cytokines dur-
ing differentiation increases the mRNA expression and
protein release of hCAP18/LL-37 and hBD-2 by
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Figure 2 Two week exposure to IL-4 or IL-13 increases the expression of the antimicrobial peptides hCAP18/LL-37 and hBD-2. PBEC
from various donors were cultured at an ALI for two weeks in the presence of various concentrations of IL-4 or IL-13. (A) Quantitative real time
PCR of LL-37 and hBD-2. Data were normalized for expression against two reference genes (b-actin and GAPDH). Data are represented as mean
± SEM of fold increase compared to medium alone for five different donors. * p < 0.05 Wilcoxon signed ranks test. (B) Densitometry results (fold
increase compared to medium alone) from the dot blot analysis of hCAP18/LL-37 expression in apical washes of ALI cultures using cells from
two donors. (C) Western Blot of LL-37 in cultures treated with medium alone (-), IL-4 (20 ng/ml), or IL-13 (20 ng/ml). From left to right: basal
medium concentrated using Oasis cartridges, apical washes, apical washes concentrated using cartridges, cell lysates, cell lysates treated with
DNaseI obtained from one culture, and a nasal secretion sample and 0.5 ng of synthetic LL-37 as controls. Similar results were obtained in basal
medium from another donor using another antibody specific for hCAP18/LL-37. (D) ELISA for hBD-2 on apical washes and basal medium; mean
± SEM of n = 3 and n = 4 experiments, respectively. (E) Two ALI cultures that were differentiated in the absence or presence of IL-4 or IL-13 for
two weeks were subsequently stimulated with 10
8 CFU heat-inactivated P. aeruginosa PAO1 or with a combination of TNF-a and IL-1b (both at
20 ng/ml) for 24 h. Quantitative real time PCR of hCAP18/LL-37. Data were normalized for expression against two reference genes (b-actin and
GAPDH). Two separate experiments are shown; data are represented as fold increase compared to medium alone.
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Page 6 of 12bronchial epithelial cells, but has an inconclusive effect
on hBD-3 expression. In addition, our data show that
hCAP18 is released into the basal medium and is
cleaved into a smaller fragment of approximately 4.5
kDa containing an epitope recognized by LL-37
antibodies.
Previously it was shown that pro-inflammatory stimuli
and bacteria increase hBD-2 expression in epithelial
cells, and the induction was inhibited when Th2 cyto-
kines were added during stimulation. We have now also
investigated whether differentiation in the presence of
IL-4 or IL-13 affected bacteria- or TNF-a/IL-1b-induced
AMP expression. In two experiments we observed that
in ALI cultures differentiated in medium alone, PAO1
and TNF-a/IL-1b induced a marked increase in hBD-2
expression, which was reduced (to a varying degree in
two donors), when cells were differentiated in the pre-
sence of IL-4, indeed suggesting that Th2 cytokines may
inhibit hBD-2 expression (data not shown). However,
hCAP18/LL-37 expression was increased to a greater
extent by IL-4 and IL-13 differentiation than by the pro-
inflammatory stimuli suggesting that differentiation of
the epithelium is important for induction of hCAP18/
LL-37 rather than pro-inflammatory stimuli (Figure 2E).
Two-week exposure of differentiating epithelial cells to
IL-4 or IL-13 does not affect the expression of SLPI and
elafin protein release
To study the effect of presence of Th2 cytokines during
differentiation on release of the antimicrobial proteinase
inhibitors SLPI and elafin, PBEC were cultured at an
ALI for 14 days in the absence or presence of various
concentrations of IL-4 and IL-13 during differentiation.
Basal medium and apical washes were harvested at the
end of the culture. No significant differences in SLPI or
elafin release in basal medium (BM) or apical wash
(AW) were found when IL-4- and IL-13-treated cultures
were compared to medium-treated cultures (Figure 3A).
In addition, no effects on mRNA expression were found
(Figure 3B). These data show that the antimicrobial pro-
tease inhibitors SLPI and elafin are not increased during
IL-4- or IL-13-induced differentiation of ALI cultures.
Two-week exposure of differentiating epithelial cells to
IL-4 or IL-13 enhances antimicrobial activity in apical
wash
To assess whether IL-4- and IL-13-treated ALI cultures
displayed antimicrobial activity, we harvested apical
wash and measured antimicrobial activity. Growth of
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Figure 3 Two week exposure to IL-4 or IL-13 does not affect the release of the antimicrobial proteinase inhibitors SLPI or elafin. PBEC
from six different donors were cultured at an ALI for 14 days in the presence of 1, 10 or 20 ng/ml of IL-4 or IL-13. (A) Basal medium (black bars)
and apical washes (gray bars) were harvested and analyzed for SLPI (upper panel) and elafin (lower panel) protein levels using sandwich ELISA.
Data are presented as mean ± SEM from experiments performed in duplicate (- n = 8; IL-4 1 ng/ml n = 3; IL-4 10 ng/ml n = 8; IL-4 20 ng/ml n
= 7; IL-13 1 ng/ml n = 3; IL-13 10 ng/ml n = 3; IL-13 20 ng/ml n = 2). (B) Quantitative real time PCR for SLPI and elafin mRNA expression. Data
are mean ± SEM of fold increase compared to medium alone for 4 independent experiments. Data were normalized for expression against two
reference genes (b-actin and GAPDH).
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Page 7 of 12Pseudomonas aeruginosa was inhibited by apical wash
obtained from six separate ALI cultures treated with IL-
4 or IL-13 (Figure 4). When compared to phosphate
buffer alone, medium-treated ALI cultures also exhibited
some antimicrobial activity (data not shown). We did
not find any antimicrobial activity in basal medium of
the IL-4- and IL-13-treated cultures.
Two-week exposure of differentiating epithelial cells to
IL-4 affects the morphology of the epithelial layer
As it was previously shown that IL-4 and IL-13 affect
b r o n c h i a le p i t h e l i a lc e l ld i f f e rentiation [13], we investi-
gated morphology and markers of ciliated and goblet
cells. Also in our cultures, differentiation in the presence
of IL-4 affects morphology; a thickened layer containing
more goblet cells is formed (Figure 5C). An increase in
MUC5AC mRNA expression was observed in IL-4- and
IL-13-treated cultures using quantitative real time PCR
(Figure 5B), whereas a reduction of FoxJ1 mRNA expres-
sion was found in 5 out of 6 donors (data not shown).
Reverse transcriptase PCR showed that IL-4 also reduced
mRNA expression of tektin and CBE-1 (other markers of
ciliated epithelial cells), whereas expression of MUC2
mRNA was enhanced (Figure 5A). MUC5B mRNA
expression was not altered by IL-4. Using dot blot analy-
sis, we observed that IL-4 slightly increased MUC5AC
protein release in five out of six experiments using cells
from four different donors (Figure 5D). These data con-
firm previous findings [10-13] by showing that also in
our cultures, two-week exposure to IL-4 during differen-
tiation alters the morphology of bronchial epithelial cells,
increases the production of MUC5AC, and decreases
expression of markers of ciliated cells.
Exposure of already differentiated bronchial epithelial
cells to IL-4 does not affect hCAP18/LL-37 expression
Next we assessed whether IL-4 also increases hCAP18/
LL-37 expression in already differentiated epithelial
layers. To this end, we differentiated bronchial epithelial
cells at an ALI for 14 days using retinoic acid to induce
mucociliary differentiation; subsequently we stimulated
the cells with 10 or 20 ng/ml of IL-4 for 48 hours and
assessed mRNA expression for hCAP18/LL-37, SLPI
and elafin. In this model, IL-4 did not induce mRNA
expression of hCAP18/LL-37 (n = 2, data not shown).
These data suggest that the altered differentiation
(increase in goblet cells) induced by IL-4 and IL-13 is
responsible for the increase in hCAP18/LL-37.
Discussion
In this study, we investigated whether the presence of
Th2 cytokines during mucociliary differentiation of
bronchial epithelial cell cultures affects antimicrobial
defence. Our results show that two-week exposure of
differentiating epithelial cells to the Th2 cytokine IL-4
induces an increase in hCAP18/LL-37 and hBD-2
mRNA and protein expression, whereas levels of the
antimicrobial proteinase inhibitors SLPI and elafin were
not affected. In addition to IL-4, also exposure to IL-13
during differentiation resulted in an increase of
hCAP18/LL-37 and hBD-2 mRNA, as well as increased
protein expression in apical washes. However, only in
basal medium of IL-4-treated cultures a peptide of
approximately 4.5 kDa was detected suggestive of the
antimicrobial peptide LL-37. Apical wash obtained from
ALI cultures treated with IL-4 or IL-13 exhibited
increased antimicrobial activity compared to medium-
treated cultures as shown by increased killing of P. aeru-
ginosa PAO1 suggesting that increased expression of
LL-37 and hBD-2 contribute to the increased antimicro-
bial activity.
In line with previous findings [12,13], in our experi-
ments IL-4 and IL-13 exposure increased MUC5AC
mRNA expression. Using various concentrations of IL-4
we also showed that MUC5AC protein expression was
increased and markers of ciliated cells were decreased,
suggesting that goblet cell hyperplasia was induced. As
we did not observe effects of IL-4 on AMPs expression
when added to already-differentiated cultures, perhaps
the IL-4- or IL-13-induced changes in differentiation
underlie the observed increased expression of antimicro-
bial peptides and increased antimicrobial activity. In
other models of differentiated epithelia, such as a model
of human gingiva [25] and in differentiated colonic
epithelium [26], increased expression of hCAP18/LL-37
and b-defensins has also been shown, and was suggested
to be related to the differentiation status. In our study,
hCAP18/LL-37 and hBD-2 expression was induced in
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Figure 4 Two week exposure to IL-4 or IL-13 enhances
antimicrobial activity. Apical wash was harvested using a 10 mM
sodium phosphate buffer pH 7.4 and added to 250 colony forming
units (CFU) of log phase P. aeruginosa PAO1 for 3 h. Bacteria were
plated to assess number of CFU. Data represent mean CFU/ml ±
SEM using apical washes obtained from six different donors.
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Page 8 of 12cultures that were differentiated in the presence of IL-4
or IL-13 which resulted in an epithelial layer resembling
goblet cell hyperplasia in e.g. asthmatic epithelium. In
contrast, short-term (48 h) IL-4 treatment of already
fully-differentiated cultures (using retinoic acid) did not
affect hCAP18/LL-37 mRNA levels. It has been shown
by others that 48 h stimulation of mucociliary differen-
tiated epithelial layers with IL-4 or IL-13 did not result
in increased release of mediators (GM-CSF and TGF-
b2), contrary to what occurs in submerged cultures [27].
These data are in concordance with our data on the
lack of effect of short term stimulation on hCAP18/LL-
37 expression by mucociliary differentiated epithelial
layers. Taken together these data suggest that increased
hCAP18/LL-37 and hBD-2 expression in airway epithe-
lial cells is perhaps related to the altered differentiation
of the epithelial cell layer. However, we have not yet
been able to identify which cell type in our ALI cultures
is responsible for the production of the antimicrobial
peptides.
In contrast to other studies showing a reduction in
PAO1- or TNFa/IL-1b-induced hBD-2 expression by
Th2 cytokines, we now show that differentiation in the
presence of IL-4 or IL-13 increases hCAP18/LL-37 and
hBD-2 expression in the absence of bacterial or pro-
inflammatory stimuli. In separate experiments we
observed that although IL-4 and IL-13 increase hBD-2
expression in our culture model, also when IL-4- or IL-
13-differentiated cultures were subsequently stimulated
with PAO1 or TNF-a/IL-1b, hBD-2 mRNA induction
by these stimuli was slightly reduced. hCAP18/LL-37
expression, however, was not affected by 24 h stimula-
tion with PAO1 or TNFa/IL-1b whereas differentiation
in the presence of IL-4 or IL-13 increased the expres-
sion. These data suggest that differentiation in the pre-
sence of Th2 cytokines alone results in increased
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Figure 5 Two week exposure to IL-4 alters the morphology and expression of markers for goblet cells and ciliated cells. (A) Expression
of mucins and markers of ciliated cells at the mRNA level in ALI cultures exposed to various concentrations of IL-4 for two weeks. (B) QPCR
analysis of MUC5AC in ALI cultures differentiated using IL-4 or IL-13. Data were normalized for expression against two reference genes (b-actin
and GAPDH). (C) Upper panels: toluidin blue staining of an untreated (left upper panel) and IL-4-treated (10 ng/ml) ALI culture (right upper
panel). Middle panels: transmission electron microscope picture of the same cultures. Lower panels: MUC5AC protein expression in an untreated
and IL-4-treated ALI culture after staining with a mouse-anti-MUC5AC antibody (clone 45M1) and goat-anti-mouse IgG-Alexa488 as a secondary
antibody. (D) MUC5AC dot blot of apical washes of ALI cultures stimulated with 10 or 20 ng/ml of IL-4 of one donor. Increase in MUC5AC
protein was observed in five out of six experiments using cells from four different donors.
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Page 9 of 12expression of AMPs, but can also hamper induction of
AMP expression by bacterial and other pro-inflamma-
tory stimuli. Whether the same effects exist when Th1
or pro-inflammatory cytokines are also present during
differentiation remains the question.
Using an antimicrobial activity assay, we have now
shown that presence of IL-4 or IL-13 during differen-
tiation leads to increased antimicrobial activity. Pre-
v i o u s l yi tw a ss h o w nt h a ta i r w a ys u r f a c ef l u i dh a sa
complex composition of various mediators including
many antimicrobial peptides [28], which may additively
or synergistically enhance antimicrobial activity. We
measured low levels of hBD-2 (1-1.5 ng/ml after IL-4
or IL-13) and were unable to detect LL-37 using a
sandwich ELISA with a 100 ng/ml lower detection
limit. It has been reported that 0.16 μg/ml of hBD-2
kills 50% of E. coli [28], whereas clinical isolates of
S. aureus were very resistant [14]. In addition it was
shown 5 μg/ml of hBD-2 was needed to kill 50% of
P. aeruginosa (clinical isolate PA-O) [29], whereas
16 μg/ml of synthetic LL-37 was needed to kill P. aer-
uginosa ATCC 27853 [30]. Since the levels of hBD-2
and LL-37 that we detected were much lower, it is
unlikely that the antimicrobial activity of apical washes
obtained from IL-4- or IL-13-treated cultures is solely
due to the activity of LL-37 or hBD-2 alone. However,
it has been shown that low (subinhibitory) concentra-
tions of LL-37, lactoferrin and SLPI synergize with
lysozyme to kill E. coli [28]. It has been previously
shown that ALI cultures of bronchial epithelial cells
express small amounts of lysozyme and lactoferrin
[31]. Using IL-9, another Th2 cytokine, in differentiat-
ing epithelial cells also results in an increase in goblet
cells and lysozyme [32]. In addition, it has been shown
that the combination of LL-37 and hBD-2 kills more S.
aureus than hBD-2 [14]. Therefore, perhaps the
increased antimicrobial activity of the apical washes of
our IL-4- and IL-13-treated cultures is due to synergis-
tic or additive effects of LL-37 or hBD-2 with lysozyme
or other compounds since the expression of both LL-
37 and hBD-2 is increased in these cultures compared
to medium-treated cultures. In the future, neutralizing
various AMPs in apical washes may provide an answer
to the question which AMPs are responsible for the
increased antimicrobial activity of IL-4- and IL-13-
treated cultures observed.
Our study has some limitations. We were not able to
detect hCAP18/LL-37 expression in washes obtained
from the apical side of the cultures using a sandwich
ELISA and SDS-PAGE followed by Western Blot,
whereas this apical wash did display antimicrobial activ-
ity. As it is known that LL-37 can bind to mucus and
DNA [33,34], perhaps epitopes are masked due to these
interactions which leads to the detection problems
found in the aforementioned assays. Another possibility
is that levels of hCAP18/LL-37 were below the detection
limits of our assays. In addition, we were only able to
detect hCAP18/LL-37 in the basal medium of IL-4-treated
cultures and not in IL-13-treated cultures, whereas
both cytokines increased mRNA and protein expres-
sion assessed by dot blot analysis. We do not think
this is due to the fact that IL-13 is less potent in indu-
cing antimicrobial substances as it was equipotent if
not more potent in the antimicrobial assay and the
induction of hBD-2 protein release. Since we also did
not detect hCAP18/LL-37 in basal medium using a
higher amount of IL-13 (100 ng/ml) during differentia-
tion (unpublished data), possibly IL-13 does not induce
sufficient secretion of hCAP18/LL-37 to the basal side,
but only to the apical side.
Which clinical implications do our results have? The
increase in AMP expression after differentiation in the
presence of Th2 cytokines may contribute to the first
line of defence, which is necessary until inflammatory
cells capable of dealing with the microbes are present at
t h es i t eo fi n v a s i o n .I ti sk n o w nt h a tn e u t r o p h i l sa r ea
potent source of hCAP18/LL-37 and neutrophil defen-
sins, and that these cells probably produce greater
amounts of these AMPs than epithelial cells. We have
not been able to measure quantifiable amounts of
hCAP18/LL-37 using the sandwich ELISA suggesting
that very low amounts (<100 pg/ml) of hCAP18/LL-37
are present in our cultures or that this method is not
suitable for detection of this AMP in our cultures. How-
ever, as the apical washes of the IL-4- and IL-13-treated
cultures displayed increased antimicrobial activity, this
confirms that the airway epithelium contributes to the
antimicrobial defence. In addition, the increase in
hCAP18/LL-37 and hBD-2 may result in increased acti-
vation of the adaptive immune response, since it is
known that these AMPs can act as chemoattractants for
phagocytes and dendritic cells, and LL-37 can affect DC
differentiation [35].
In conclusion, differentiation of epithelium in the pre-
sence of Th2 cytokines IL-4 and IL-13 results in an
altered epithelial layer that not only produces more
mucus, but also more hCAP18/LL-37 and hBD-2, and
displays increased antimicrobial activity.
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